Variant report
Variant | esv3400907 |
---|---|
Chromosome Location | chr6:166698836-166699266 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7746728 | chr6:166698866-166698867 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs73043970 | chr6:166698920-166698921 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs141017117 | chr6:166698929-166698930 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368454493 | chr6:166698934-166698935 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs114751079 | chr6:166698941-166698942 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs7742690 | chr6:166698942-166698943 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs73043971 | chr6:166698959-166698960 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs112521780 | chr6:166698972-166698973 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
9 | rs75923059 | chr6:166699000-166699001 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs9365995 | chr6:166699087-166699088 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs371327771 | chr6:166699120-166699121 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs6904767 | chr6:166699150-166699151 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs186901380 | chr6:166699167-166699168 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs150265337 | chr6:166699231-166699232 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
Chordoma | 18071362 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Epilepsy | 22083797 | CNVD |
Myelofibrosis | 22110671 | CNVD |
chordoma | 19801981 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Autism | 17483303 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Ependymoma | 20639864 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:166687600-166704800 | Weak transcription | Right Atrium | heart |
2 | chr6:166691200-166706000 | Weak transcription | Brain Anterior Caudate | brain |
3 | chr6:166697400-166699200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
4 | chr6:166698000-166699000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
5 | chr6:166698200-166699000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
6 | chr6:166698400-166699000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr6:166698400-166705800 | Weak transcription | Brain Cingulate Gyrus | brain |
8 | chr6:166698800-166699000 | Bivalent Enhancer | K562 | blood |
9 | chr6:166698800-166699600 | Enhancers | GM12878-XiMat | blood |
10 | chr6:166698800-166700200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr6:166699200-166700200 | Enhancers | Primary B cells from peripheral blood | blood |
12 | chr6:166699200-166700400 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
13 | chr6:166699200-166700400 | Enhancers | Primary B cells from cord blood | blood |